Appropriate Cardiac Cath Lab activation: Optimizing electrocardiogram interpretation and clinical decision-making for acute ST-elevation myocardial infarction

2010 ◽  
Vol 160 (6) ◽  
pp. 995-1003.e8 ◽  
Author(s):  
Ivan C. Rokos ◽  
William J. French ◽  
Amal Mattu ◽  
Graham Nichol ◽  
Michael E. Farkouh ◽  
...  
Author(s):  
Kuan-Cheng Chang ◽  
Po-Hsin Hsieh ◽  
Mei-Yao Wu ◽  
Yu-Chen Wang ◽  
Jung-Ting Wei ◽  
...  

Abstract Aim To develop an artificial intelligence-based approach with multi-labeling capability to identify both ST-elevation myocardial infarction (STEMI) and 12 heart rhythms based on 12-lead ECGs. Methods We trained, validated, and tested a long short-term memory (LSTM) model for the multi-label diagnosis of 13 ECG patterns (STEMI+12 rhythm classes) using 60,537 clinical ECGs from 35,981 patients recorded between Jan 15, 2009 and Dec 31, 2018. In addition to the internal test above, we conducted a real-world external test, comparing the LSTM model with board-certified physicians of different specialties using a separate dataset of 308 ECGs covering all 13 ECG diagnoses. Results In the internal test, the area under curves (AUCs) of the LSTM model in classifying the 13 ECG patterns ranged between 0.939 and 0.999. For the external test, the LSTM model for multi-labeling of the 13 ECG patterns evaluated by AUC was 0.987±0.021, which was superior to those of cardiologists (0.898±0.113, P < 0.001), emergency physicians (0.820±0.134, P < 0.001), internists (0.765±0.155, P < 0.001), and a commercial algorithm (0.845±0.121, P < 0.001). Of note, the LSTM model achieved an accuracy of 0.987, AUC of 0.997, and precision, recall, and F  1 score of 0.952, 0.870, and 0.909, respectively, in detecting STEMI. Conclusions We demonstrated the usefulness of an LSTM model in the multi-labeling detection of both rhythm classes and STEMI in competitive testing against board-certified physicians. This AI tool exceeding the cardiologist-level performance in detecting STEMI and rhythm classes on 12-lead ECG may be useful in prioritizing chest pain triage and expediting clinical decision making in healthcare.


Open Heart ◽  
2018 ◽  
Vol 5 (2) ◽  
pp. e000810 ◽  
Author(s):  
Ivo M van Dongen ◽  
Joëlle Elias ◽  
K Gert van Houwelingen ◽  
Pierfrancesco Agostoni ◽  
Bimmer E P M Claessen ◽  
...  

ObjectiveThe impact on cardiac function of collaterals towards a concomitant chronic total coronary occlusion (CTO) in patients with ST-elevation myocardial infarction (STEMI) has not been investigated yet. Therefore, we have evaluated the impact of well-developed collaterals compared with poorly developed collaterals to a concomitant CTO in STEMI.Methods and resultsIn the EXPLORE trial, patients with STEMI and a concomitant CTO were randomised to either CTO percutaneous coronary intervention (PCI) or no-CTO PCI. Collateral grades were scored angiographically using the Rentrop grade classification. Left ventricular ejection fraction (LVEF) and left ventricular end-diastolic volume (LVEDV) at 4 months were measured using cardiac magnetic resonance imaging. Well-developed collaterals (Rentrop grades 2–3) to the CTO were present in 162 (54%) patients; these patients had a significantly higher LVEF at 4 months (46.2±11.4% vs 42.1±12.7%, p=0.004) as well as a trend for a lower LVEDV (208.2±55.7 mL vs 222.6±68.5 mL, p=0.054) when compared with patients with poorly developed collaterals to the CTO. There was no significant difference in the total amount of scar in the two groups. Event rates were statistically comparable between patients with well-developed collaterals and poorly developed collaterals to the CTO at long-term follow-up.ConclusionsIn patients with STEMI and a concomitant CTO, the presence of well-developed collaterals to a concomitant CTO is associated with a better LVEF at 4 months. However, this effect on LVEF did not translate into improvement in clinical outcome. Therefore, the presence of well-developed collaterals is important, but should not solely guide in the clinical decision-making process regarding any additional revascularisation of a concomitant CTO in patients with STEMI.Clinical trial registrationNTR1108.


Sign in / Sign up

Export Citation Format

Share Document